Evidence map›Paper›PMID 41080080›Full record

ArticleJournal of toxicologic pathology2025

Canine generalized ceroid lipofuscinosis characterized by predominant deposition in pancreatic acinar cells and intestinal smooth muscle cells.

Ryoko Fujikawa, Kyohei Yasuno, Masako Imaoka, Shinobu Hakamata, Kumi Honda, Keiko Okado, Hitomi Shimoda, Yoshimi Tsuchiya

Abstract readCase Reports
In one paragraph

Article in Journal of toxicologic pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryoko FujikawaMedicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-kasai, Edogawa-ku, Tokyo 134-8630, Japan.
Kyohei YasunoMedicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-kasai, Edogawa-ku, Tokyo 134-8630, Japan.
Masako ImaokaMedicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-kasai, Edogawa-ku, Tokyo 134-8630, Japan.
Shinobu HakamataMedicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-kasai, Edogawa-ku, Tokyo 134-8630, Japan.
Kumi HondaMedicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-kasai, Edogawa-ku, Tokyo 134-8630, Japan.
Keiko OkadoTranslational Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-kasai, Edogawa-ku, Tokyo 134-8630, Japan.
Hitomi ShimodaDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.
Yoshimi TsuchiyaMedicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-kasai, Edogawa-ku, Tokyo 134-8630, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canine generalized ceroid lipofuscinosis (GCL) is a rare disease characterized by the deposition of lipofuscin in systemic organs and tissues. In this case report, we encountered a dog with GCL and performed a detailed histopathological examination. A 7-year-old male beagle was euthanized due to progressive weight loss and loose or bloody stools, without any neurological symptoms. Histopathologically, deposition of lipofuscin was observed in the parenchymal cells of systemic organs, particularly in the pancreatic acini and intestinal smooth muscle, accompanied by interstitial infiltration of macrophages. No neuronal loss was observed in the central nervous system, despite such findings and neurological symptoms being commonly associated with GCL. However, some lipofuscin deposition was evident in systemic organs, so the present case was diagnosed as GCL characterized by predominant deposition in the pancreatic acini and intestinal smooth muscle. This detailed description of the morphological features may contribute to a deeper understanding of lipofuscinosis.

Indexed as

dogintestinelipofuscinlipofuscinosispancreas

Identifiers

PMID41080080
PMCPMC12509281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.